Administration of caseinomacropeptide-enriched extract to mice enhances the calcium content of femur in a low-calcium diet

P. Burns, A. Binetti, P. Torti, U. Kulozik, L. Forzani, P. Renzulli, G. Vinderola, J. Reinheimer

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Caseinomacropeptide (CMP) is the 64C-terminal amino acid residue of κ-casein, formed by chymosin cleavage during cheese manufacture. This study examined the effects of oral administration of a CMP-enriched extract (CMPEE), obtained from a local dairy plant, on the Ca content of mouse femurs. Animals received low (0.1%, w/v), normal (0.5%, w/v) or high (1.2%, w/v) Ca diet for 3 or 8 weeks and CMPEE diluted (1:10) in their drinking water. No significant differences in Ca content were observed in faeces, kidney, urine or blood serum compared with control animals. The oral administration of CMP to mice significantly enhanced the Ca content in femur under a low-Ca diet model, especially during the period of full body development (3 weeks), in which case a significant 12% Ca increase was observed. These findings pave the way for further studies aimed at supplementing infant food with industrially-obtained CMP-enriched extract for enhanced bone health.

Original languageEnglish
Pages (from-to)15-20
Number of pages6
JournalInternational Dairy Journal
Volume44
DOIs
StatePublished - 1 May 2015

Fingerprint

Dive into the research topics of 'Administration of caseinomacropeptide-enriched extract to mice enhances the calcium content of femur in a low-calcium diet'. Together they form a unique fingerprint.

Cite this